title: Response: physostigmine may not be the only option for treating anticholinergic syndrome.
authors.affiliation: Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, VA, USA, thomas.pluim@med.navy.mil.
authors.forename: Thomas
authors.initials: T
authors.lastname: Pluim
mesh_terms: D018680:Cholinergic Antagonists / Q000506:poisoning*; D020927:Dexmedetomidine / Q000627:therapeutic use*; D004155:Diphenhydramine / Q000506:poisoning*; D005260:Female; D006801:Humans
chemical_list: D018680:Cholinergic Antagonists; D020927:Dexmedetomidine; D004155:Diphenhydramine